The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1088-1099

  Janic, Branislava ^a   Arbab, Ali S ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Angiogenesis; Endothelial progenitor cells; Imaging probes; Tumor; Vasculogenesis

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CANCER GROWTH; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL MIGRATION; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LYMPHANGIOGENESIS; METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; STEM CELL; TUMOR GROWTH; CYTOLOGY; ENDOTHELIUM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); REVIEW; VASCULARIZATION;

ENDOTHELIUM; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 77955875027     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.100     Document Type: Short Survey

References (76)

1. Gimbrone, M.A., Jr., Leapman, S.B., et al. (1972) Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136(2), 261-276.
2. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3), 353-364. (Pubitemid 26272076)
3. Carmeliet, P. and Jain, R.K. (2000) Angiogenesis in cancer and other diseases. Nature 407(6801), 249-257.
4. Bergers, G. and Benjamin, L.E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3(6), 401-410.
5. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438(7070), 932-936.
6. Jain, R.K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706), 58-62.
7. Narazaki, M. and Tosato, G. (2006) Tumor cell populations differ in angiogenic activity: a model system for spontaneous angiogenic switch can tell us why. J. Natl. Cancer Inst. 98(5), 294-295. (Pubitemid 43338209)
8. Risau, W. and Flamme, I. (1995) Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91.
9. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267(16), 10931-10934.
10. Folkman, J. (1995) Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333(26), 1757-1763.
11. Dome, B., Hendrix, M.J., et al. (2007) Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am. J. Pathol. 170(1), 1-15. (Pubitemid 47339184)
12. Hillen, F. and Griffioen, A.W. (2007) Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 26(3-4), 489-502. (Pubitemid 350115123)
13. Hladovec, J. (1978) Circulating endothelial cells as a sign of vessel wall lesions. Physiol. Bohemoslov. 27(2), 140-144. (Pubitemid 8351343)
14. Hladovec, J., Prerovsky, I., et al. (1978) Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin. Wochenschr. 56(20), 1033-1036. (Pubitemid 9036941)
15. Sowemimo-Coker, S.O., Meiselman, H.J., et al. (1989) Increased circulating endothelial cells in sickle cell crisis. Am. J. Hematol. 31(4), 263-265.
16. Scott, S.M., Barth, M.G., et al. (1994) The role of circulating cells in the healing of vascular prostheses. J. Vasc. Surg. 19(4), 585-593.
17. Solovey, A., Lin, Y., et al. (1997) Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337(22), 1584-1590. (Pubitemid 27509761)
18. Asahara, T., Murohara, T., et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-967. (Pubitemid 27087709)
19. Khakoo, A.Y. and Finkel, T. (2005) Endothelial progenitor cells. Annu. Rev. Med. 56, 79-101.
20. Shi, Q., Rafii, S., et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92(2), 362-367. (Pubitemid 28323695)
21. Gehling, U.M., Ergun, S., et al. (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95(10), 3106-3112. (Pubitemid 30321161)
22. Peichev, M., Naiyer, A.J., et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95(3), 952-958. (Pubitemid 30062717)
23. Miraglia, S., Godfrey, W., et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90(12), 5013-5021. (Pubitemid 28007218)
24. Handgretinger, R., Gordon, P.R., et al. (2003) Biology and plasticity of CD133+ hematopoietic stem cells. Ann. N. Y. Acad. Sci. 996, 141-151. (Pubitemid 36706596)
25. Mizrak, D., Brittan, M., et al. (2008) CD133: molecule of the moment. J. Pathol. 214(1), 3-9.
26. Heissig, B., Hattori, K., et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109(5), 625-637. (Pubitemid 34628725)
27. Banai, S., Shweiki, D., et al. (1994) Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc. Res. 28(8), 1176-1179. (Pubitemid 24264723)
28. Ceradini, D.J., Kulkarni, A.R., et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF- 1 induction of SDF-1. Nat. Med. 10(8), 858-864.
29. Shweiki, D., Itin, A., et al. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 359(6398), 843-845.
30. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386(6626), 671-674.
31. Yamaguchi, J., Kusano, K.F., et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107(9), 1322-1328.
32. Grunewald, M., Avraham, I., et al. (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1), 175-189.
33. Arbab, A.S., Janic, B., et al. (2008) Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J. 22(9), 3234-3246.
34. Kryczek, I., Lange, A., et al. (2005) CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 65(2), 465-472.
35. Schatteman, G.C., Dunnwald, M., et al. (2007) Biology of bone marrow-derived endothelial cell precursors. Am. J. Physiol. Heart Circ. Physiol. 292(1), H1-18.
36. Kollet, O., Spiegel, A., et al. (2001) Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 97(10), 3283-3291.
37. Spring, H., Schuler, T., et al. (2005) Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl. Acad. Sci. U. S. A. 102(50), 18111-18116.
38. Suriano, R., Chaudhuri, D., et al. (2008) 17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Res. 68(15), 6038-6042.
39. Adriaenssens, E., Vanhecke, E., et al. (2008) Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 68(2), 346-351.
40. Lagadec, C., Meignan, S., et al. (2009) TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 28(18), 1960-1970.
41. Kermani, P., Rafii, D., et al. (2005) Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J. Clin. Invest. 115(3), 653-663.
42. Shibata, R., Skurk, C., et al. (2008) Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett. 582(11), 1607-1612.
43. Landskroner-Eiger, S., Qian, B., et al. (2009) Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin. Cancer Res. 15(10), 3265-3276.
44. Nakamura, N., Naruse, K., et al. (2009) Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1. FEBS Lett. 583(15), 2457-2463.
45. Urbich, C. and Dimmeler, S. (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95(4), 343-353.
46. Janic, B., Guo, A.M., et al. (2010) Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 5(2), e9173.
47. Lyden, D., Hattori, K., et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7(11), 1194-1201.
48. Hilbe, W., Dirnhofer, S., et al. (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J. Clin. Pathol. 57(9), 965-969.
49. Dome, B., Timar, J., et al. (2006) Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res. 66(14), 7341-7347.
50. Igreja, C., Courinha, M., et al. (2007) Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 92(4), 469-477.
51. Peters, B.A., Diaz, L.A., et al. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med. 11(3), 261-262.
52. Young, P.P., Vaughan, D.E., et al. (2007) Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog. Cardiovasc. Dis. 49(6), 421-429.
53. Purhonen, S., Palm, J., et al. (2008) Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 105(18), 6620-6625.
54. Nolan, D.J., Ciarrocchi, A., et al. (2007) Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 21(12), 1546-1558.
55. Singh Jaggi, J., Henke, E., et al. (2007) Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization. PLoS One 2(3), e267.
56. Arbab, A.S., Pandit, S.D., et al. (2006) Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24(3), 671-678.
57. Zheng, P.P., Hop, W.C., et al. (2007) Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas. Ann. Neurol. 62(1), 40-48.
58. Rafat, N., Beck, G., et al. (2010) Circulating endothelial progenitor cells in malignant gliomas. J. Neurosurg. 112(1), 43-49.
59. Massa, M., Rosti, V., et al. (2005) Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. J. Clin. Oncol. 23(24), 5688-5695.
60. Wierzbowska, A., Robak, T., et al. (2005) Circulating endothelial cells in patients with acute myeloid leukemia. Eur. J. Haematol. 75(6), 492-497. (Pubitemid 41693370)
61. Yu, D., Sun, X., et al. (2007) Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin. Cancer Res. 13(13), 3814-3824.
62. Willett, C.G., Boucher, Y., et al. (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med. 10(2), 145-147.
63. Zhang, H., Vakil, V., et al. (2005) Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 105(8), 3286-3294.
64. Richter-Ehrenstein, C., Rentzsch, J., et al. (2007) Endothelial progenitor cells in breast cancer patients. Breast Cancer Res. Treat. 106(3), 343-349.
65. Naik, R.P., Jin, D., et al. (2008) Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res. Treat. 107(1), 133-138.
66. Brown, A.B., Yang, W., et al. (2003) Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther. 14(18), 1777-1785.
67. Nakamura, K., Ito, Y., et al. (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 11(14), 1155-1164.
68. Moore, X.L., Lu, J., et al. (2004) Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther. 11(10), 811-818.
69. Anderson, S.A., Glod, J., et al. (2005) Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105(1), 420-425.
70. Arbab, A.S., Iskander, et A.S.M., al. (2006) Migration of endothelial progenitor cells is related to HIF-1a induced SDF-1 expression. Mol. Imaging 5(3), 233.
71. Ferrari, N., Glod, J., et al. (2003) Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther. 10(8), 647-656.
72. Tai, C.K. and Kasahara, N. (2008) Replication-competent retrovirus vectors for cancer gene therapy. Front. Biosci. 13, 3083-3095.
73. Jevremovic, D., Gulati, R., et al. (2004) Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors. Am. J. Physiol. Heart Circ. Physiol. 287(2), H494-500.
74. Rad, A.M., Iskander, A.S., et al. (2009) AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study. BMC Biotechnol. 9, 28.
75. Munter, M.W., Karger, C.P., et al. (1999) Delayed vascular injury after single high-dose irradiation in the rat brain: histologic immunohistochemical, and angiographic studies. Radiology 212(2), 475-482.
76. Murakami, J., Li, T.S., et al. (2009) Inhibition of accelerated tumor growth by blocking the recruitment of mobilized endothelial progenitor cells after chemotherapy. Int. J. Cancer 124(7), 1685-1692.